Built on an evolutionary engine first released in 2018, STAR Fuzzer by Bright Security finds crashes, memory exhaustion and ...

Bright Security Introduces STAR Fuzzer, Agentic Fuzzing That Writes Its Own Harnesses and Proves Every Finding ...

There Is Something We Have to Do Right Now About A.I. Artificial intelligence labs are on the verge of handing over the training of A.I. to A.I. We should stop them. There’s a chasm right now between ...

We must stop companies from allowing AI to self-improve into an uncontrollable level of intelligence Major AI lab CEOs advocated for slowing the pace of AI development this weekend. They are right to ...

The US-China race for artificial intelligence dominance has entered a new phase: using AI to build better AI. Leading AI companies in the United States and China are increasingly focused on deploying ...

In a social media post, Dario Amodei proposed a plan including third-party evaluations of AI systems The CEO of the artificial intelligence company Anthropic issued a new appeal on Saturday for the AI ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Jeff Dean, one of the longest-serving and most influential executives at Google, is stepping down from the search giant to launch his own AI startup. Coming with him as co-founders are several other ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

Private equity giant KKR will take Integer Holdings private in an all-cash deal valued at about $5.7 billion, the medical-device outsourcing firm said on Monday. Shares of Plano, Texas-based Integer ...